Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1954 1
1957 1
1961 2
1964 3
1965 2
1967 1
1969 4
1970 1
1971 6
1972 5
1973 11
1974 10
1975 3
1976 4
1977 2
1978 2
1979 1
1980 2
1982 10
1983 3
1984 7
1985 8
1986 6
1987 4
1988 7
1989 10
1990 5
1991 7
1992 8
1993 10
1994 10
1995 11
1996 9
1997 10
1998 14
1999 17
2000 6
2001 11
2002 7
2003 9
2004 6
2005 9
2006 10
2007 5
2008 8
2009 8
2010 13
2011 10
2012 9
2013 16
2014 10
2015 9
2016 7
2017 9
2018 1
2019 4
2020 2
2021 7
2022 7
2023 9
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

390 results

Results by year

Filters applied: . Clear all
Page 1
Polyamine-iron chelator conjugate.
Bergeron RJ, McManis JS, Franklin AM, Yao H, Weimar WR. Bergeron RJ, et al. J Med Chem. 2003 Dec 4;46(25):5478-83. doi: 10.1021/jm0302694. J Med Chem. 2003. PMID: 14640556
The Good and Bad Sides of NAAG.
Khacho P, Wang B, Bergeron R. Khacho P, et al. Among authors: bergeron r. Adv Pharmacol. 2016;76:311-49. doi: 10.1016/bs.apha.2016.01.003. Epub 2016 Mar 2. Adv Pharmacol. 2016. PMID: 27288081 Review.
NAAG, NMDA receptor and psychosis.
Bergeron R, Coyle JT. Bergeron R, et al. Curr Med Chem. 2012;19(9):1360-4. doi: 10.2174/092986712799462685. Curr Med Chem. 2012. PMID: 22304714 Free PMC article. Review.
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, Luthra S, Garrett TJ, Guingab-Cagmat J, Plant D, Bose P, Cusi K, Hromas RA, Tischler AS, Powers JF, Gupta P, Bibb J, Beuschlein F, Robledo M, Calsina B, Timmers H, Taieb D, Kroiss M, Richter S, Langton K, Eisenhofer G, Bergeron R Jr, Pacak K, Tevosian SG, Ghayee HK. Rai SK, et al. Among authors: bergeron r jr. Metabolism. 2020 Sep;110:154297. doi: 10.1016/j.metabol.2020.154297. Epub 2020 Jun 18. Metabolism. 2020. PMID: 32562798 Free PMC article.
[Play therapy].
Bergeron R. Bergeron R. Vie Med Can Fr. 1974 Aug;3(8):782-7. Vie Med Can Fr. 1974. PMID: 4410416 French. No abstract available.
Fluorescent Lipoprotein Probe.
Bergeron R, Scott J. Bergeron R, et al. Anal Biochem. 1982 Jan 1;119(1):128-34. doi: 10.1016/0003-2697(82)90675-3. Anal Biochem. 1982. PMID: 7072934 No abstract available.
The desferrithiocin pharmacophore.
Bergeron RJ, Liu CZ, McManis JS, Xia MX, Algee SE, Wiegand J. Bergeron RJ, et al. J Med Chem. 1994 May 13;37(10):1411-7. doi: 10.1021/jm00036a005. J Med Chem. 1994. PMID: 8182699
390 results